STOCK TITAN

Insulet Corp - PODD STOCK NEWS

Welcome to our dedicated page for Insulet news (Ticker: PODD), a resource for investors and traders seeking the latest updates and insights on Insulet stock.

Insulet Corporation (PODD) delivers innovative diabetes management solutions through its flagship Omnipod® insulin pump system. This page aggregates official news and developments about the company's medical device innovations, financial performance, and strategic initiatives.

Investors and healthcare professionals will find timely updates including quarterly earnings reports, product launch announcements, regulatory milestones, and partnership agreements. All content is sourced directly from verified corporate communications to ensure accuracy.

Key coverage areas include FDA clearances for new devices, clinical study results, international market entries, and technology partnerships enhancing insulin delivery systems. The resource is particularly valuable for tracking advancements in tubeless pump technology and automated insulin dosing integrations.

Bookmark this page for streamlined access to Insulet's latest developments in diabetes care innovation. Check regularly for updates that may impact long-term growth strategies or patient care standards.

Rhea-AI Summary
Insulet Corporation (PODD) announces new appointments to its Board of Directors and the retirement of two board members. Flavia Pease and Timothy Stonesifer will join the Board, while Shacey Petrovic and Corinne Nevinny will retire at the Company's 2024 Annual Meeting. The new appointees bring extensive industry expertise and distinguished careers to support and enhance the company's commitment to excellence and innovation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.27%
Tags
management
-
Rhea-AI Summary
Insulet Corporation (PODD) to Release Q4 and Full Year 2023 Financial Results on February 22, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.21%
Tags
-
Rhea-AI Summary
Insulet Corporation (PODD) to present at Nasdaq 29th Investor Conference in London and J.P. Morgan Annual Healthcare Conference in San Francisco. Live audio webcasts and replays available on investors.insulet.com/events.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
conferences
Rhea-AI Summary
Insulet Corporation (NASDAQ: PODD) announced its financial results for the third quarter of 2023. The company reported revenue of $432.7 million, up 27.0% compared to the prior year. Gross margin increased to 67.8%, and operating income increased to $54.8 million. Net income was $51.9 million, compared to a net loss of $5.2 million in the prior year. The company raised its full-year revenue guidance to a range of 26% to 27%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.76%
Tags
-
Rhea-AI Summary
Insulet Corporation announced a series of initiatives in recognition of National Diabetes Awareness Month and World Diabetes Day. The company will ring the closing bell at Nasdaq Stock Market on November 14 and will host educational events. Insulet is committed to raising awareness and providing support for people with diabetes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.88%
Tags
none
-
Rhea-AI Summary
Sensata Technologies announced that Brian K. Roberts has been named as the new CFO, succeeding Paul Vasington who will retire. Brian will assume leadership of all global financial activities. Brian brings decades of finance and leadership experience, including as CFO at Insulet Corporation and Digitas, Inc. Sensata will conduct a conference call to discuss its Q3 2023 financial results and outlook for Q4 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.38%
Tags
none
Rhea-AI Summary
Insulet Corporation has received FDA clearance for the Omnipod 5 App for iPhone, making it the first company to offer a tubeless automated insulin delivery system with full control from a compatible Android and iOS smartphone.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.57%
Tags
-
News
Rhea-AI Summary
Insulet Corporation reaffirms guidance for Q3 and FY 2023, announces CFO resignation and interim replacement
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.02%
Tags
none
-
Rhea-AI Summary
Insulet Corporation announces schedule of events and presentations at EASD 2023, highlighting extended real-world evidence of improved outcomes using Omnipod 5 Automated Insulin Delivery System.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.48%
Tags
conferences
Rhea-AI Summary
Insulet Corporation plans to release its financial results for Q3 2023 on November 2, 2023. A conference call will be hosted at 4:30 p.m. (Eastern Time).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.34%
Tags
Insulet Corp

Nasdaq:PODD

PODD Rankings

PODD Stock Data

17.33B
69.72M
0.38%
102.96%
4.09%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ACTON